SASPject PT 3.9
Alternative Names: PT 3.9; SASPject™ PT 3.9Latest Information Update: 03 May 2021
At a glance
- Originator Phico Therapeutics
- Class Antibacterials; Bacteriophages; DNA-binding proteins; Gene therapies
- Mechanism of Action Bacterial DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pseudomonal infections